This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Hewlett Packard Enterprise (HPE) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Hewlett Packard Enterprise (HPE) and Bruker (BRKR) have performed compared to their sector so far this year.
Bruker (BRKR) Assay to Offer Reliable Omicron Variant Detection
by Zacks Equity Research
Bruker's (BRKR) FluoroType SARS-CoV-2 varID Q assay is anticipated to provide reliable detection of the novel Omicron (B.1.1.529) variant of SARS-CoV-2.
Bruker (BRKR) Down 0.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Invest In Bruker (BRKR) Stock for Now
by Zacks Equity Research
Investors are optimistic about Bruker's (BRKR) better-than-expected results and strong segmental performance.
Bruker (BRKR) Advances in Proteomics Workflow With New Pacts
by Zacks Equity Research
Talking about these three developments, Bruker (BRKR) notes that because of complex sample preparation protocols, the widespread adoption of proteomics has been limited.
Bruker (BRKR) Q3 Earnings Surpass Estimates, Margins Up
by Zacks Equity Research
Bruker (BRKR) reports better-than-expected earnings and revenues for the third quarter of 2021 on geographical performance driving the top line.
Bruker (BRKR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of 40.00% and 5.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NuVasive (NUVA) Announces Two Developments in Cohere TLIF Line
by Zacks Equity Research
According to NuVasive (NUVA), Porous PEEK is a clear differentiator for the company in the market.
Badger Meter's (BMI) Q3 Earnings Beat on Top-Line Growth
by Zacks Equity Research
Badger Meter (BMI) reports strong third-quarter 2021 results with net earnings and revenues increasing year over year, driven by healthy order momentum and higher adoption of digital solutions.
Thermo Fisher (TMO) Boosts COVID Testing With Wastewater Kit
by Zacks Equity Research
Thermo Fisher's (TMO) wastewater surveillance method is set to identify asymptomatic carriers on college campuses to monitor regional spread among communities.
After Plunging 14% in 4 Weeks, Here's Why the Trend Might Reverse for Bruker (BRKR)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Bruker (BRKR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Bruker (BRKR) Up 9.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bruker (BRKR) Hits a New 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Bruker (BRKR) on solid BSI Nano Group growth potential and raised 2021 financial guidance.
Syneos Health (SYNH) Q2 Earnings Top Estimates, 2021 View Up
by Zacks Equity Research
Syneos Health (SYNH) reported better-than-expected revenues for the second quarter of 2021 on strong segmental performance.
Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up
by Zacks Equity Research
Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.
Insulet (PODD) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Insulet (PODD) reports better-than-expected revenues for second-quarter 2021 on strong performance of Omnipod, both in U.S. and international markets.
Tandem Diabetes (TNDM) Q2 Earnings Rise Y/Y, Sales View Up
by Zacks Equity Research
Tandem Diabetes (TNDM) reports better-than-expected revenues for second quarter 2021 on strong domestic and international pump shipments driving the top line.
Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Grow
by Zacks Equity Research
Amedisys (AMED) reports better-than-expected earnings for the second quarter with strong performance in Home Health and Hospice segments.
Bruker (BRKR) Q2 Earnings Beat Estimates, 2021 Guidance Up
by Zacks Equity Research
Bruker (BRKR) reports better-than-expected revenues for the second quarter of 2021 on strong segmental performance driving the top line.
Bruker (BRKR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of 10.00% and 6.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Qorvo (QRVO) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Qorvo's (QRVO) fiscal first-quarter results are likely to reflect continued strength in its 5G mobile products and Wi-Fi 6 devices, and increased demand for defense solutions.
Bruker (BRKR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Bruker (BRKR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Microchip (MCHP) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Microchip's (MCHP) fiscal first-quarter results are likely to reflect robust uptake of microcontrollers amid uptick in demand across automotive, consumer, industrial, and medical end-markets.
IPG Photonics (IPGP) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
IPG Photonics' (IPGP) Q2 results are likely to reflect momentum in new end-markets and fiber lasers for urological and dental procedures.